CapsoVision, Inc. Logo

CapsoVision, Inc. (CV)

NASDAQ

Currency in USD
5.86
+0.03 (+0.51%)

Closed

Aug 25, 2026

Day's Range

5.79
6.00

52 wk Range

3.43
15.37

Overview - CV - CapsoVision, Inc.

Key Statistics

Valuation

Enterprise Value

283.38M

P/E (Trailing)

‪-5.65‬

P/E (Forward)

‪-13.53‬

PEG Ratio

‪-0.36‬

Price / Sales (TTM)

‪21.00‬

Price / Book

‪22.16‬

EV / EBITDA

‪-9.58‬

Profitability

Gross Margin

‪47.60%‬

Profit Margin

‪-214.73%‬

Operating Margin

‪-208.07%‬

Return on Assets

‪-132.47%‬

Return on Equity

‪-335.06%‬

Ownership

Shares Outstanding

49.83M

Float

31.49M

Short % of Shares Outstanding

‪5.10%‬

Held by Insiders

‪32.03%‬

Held by Institutions

‪10.34%‬

Price stats

50-Day Avg

‪6.65‬

200-Day Avg

‪6.75‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

1 analysts

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - CV - CapsoVision, Inc.

Peers - CV - CapsoVision, Inc.

Peer Comparison

Compared with companies in Medical Devices listed on NASDAQ.

Profile Summary - CV - CapsoVision, Inc.

About

CapsoVision, Inc. is a commercial-stage medical technology company specializing in advanced imaging and artificial intelligence technologies for endoscopy solutions. It focuses on identifying abnormalities in the gastrointestinal tract for diagnostic and screening purposes. The company's core product is the CapsoCam…

SectorHealthcare
IndustryMedical Devices
Employees90
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.